ATE213648T1 - Arzneimittel enthaltend blutplättchenaggregationsinhibitoren - Google Patents

Arzneimittel enthaltend blutplättchenaggregationsinhibitoren

Info

Publication number
ATE213648T1
ATE213648T1 AT96940256T AT96940256T ATE213648T1 AT E213648 T1 ATE213648 T1 AT E213648T1 AT 96940256 T AT96940256 T AT 96940256T AT 96940256 T AT96940256 T AT 96940256T AT E213648 T1 ATE213648 T1 AT E213648T1
Authority
AT
Austria
Prior art keywords
platele
products containing
medicinal products
aggregation inhibitors
aggregation
Prior art date
Application number
AT96940256T
Other languages
English (en)
Inventor
Karl M Gelotte
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603721.3A external-priority patent/GB9603721D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE213648T1 publication Critical patent/ATE213648T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT96940256T 1995-10-27 1996-10-23 Arzneimittel enthaltend blutplättchenaggregationsinhibitoren ATE213648T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US590795P 1995-10-27 1995-10-27
GBGB9603721.3A GB9603721D0 (en) 1996-02-22 1996-02-22 Composition for inhibiting platelet aggregation
PCT/US1996/017193 WO1997015328A1 (en) 1995-10-27 1996-10-23 Pharmaceutical compositions containing platelet aggregation inhibitors

Publications (1)

Publication Number Publication Date
ATE213648T1 true ATE213648T1 (de) 2002-03-15

Family

ID=26308777

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96940256T ATE213648T1 (de) 1995-10-27 1996-10-23 Arzneimittel enthaltend blutplättchenaggregationsinhibitoren

Country Status (35)

Country Link
EP (1) EP0859634B1 (de)
JP (1) JP3452367B2 (de)
KR (1) KR100362799B1 (de)
CN (1) CN1158107C (de)
AT (1) ATE213648T1 (de)
AU (1) AU712755B2 (de)
BG (1) BG63623B1 (de)
BR (1) BR9610878A (de)
CA (1) CA2234364C (de)
CO (1) CO4770960A1 (de)
CY (1) CY2292B1 (de)
CZ (1) CZ290381B6 (de)
DE (1) DE69619540T2 (de)
DK (1) DK0859634T3 (de)
DZ (1) DZ2110A1 (de)
EA (1) EA000628B1 (de)
EE (1) EE03518B1 (de)
ES (1) ES2171749T3 (de)
HK (1) HK1017846A1 (de)
HU (1) HU228757B1 (de)
IL (1) IL123790A (de)
IS (1) IS1948B (de)
MX (1) MX9803275A (de)
MY (1) MY116837A (de)
NO (1) NO324415B1 (de)
NZ (1) NZ323134A (de)
PL (1) PL185744B1 (de)
PT (1) PT859634E (de)
SA (1) SA96170527B1 (de)
SI (1) SI0859634T1 (de)
SK (1) SK282353B6 (de)
TR (1) TR199800716T2 (de)
TW (1) TW385248B (de)
UA (1) UA45423C2 (de)
WO (1) WO1997015328A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ633900A0 (en) 2000-03-20 2000-04-15 Jurox Pty Ltd Anaesthetic composition
CN1322863C (zh) * 2004-10-29 2007-06-27 武汉远大制药集团股份有限公司 一种抑制血小板凝聚的注射液及其制备方法
CN100386079C (zh) * 2005-03-24 2008-05-07 武汉远大制药集团股份有限公司 一种抑制血小板凝聚的注射用粉针及其制备方法
CN100367961C (zh) * 2005-09-30 2008-02-13 天津南开允公医药科技有限公司 盐酸替罗非班冻干粉针注射剂及其制备方法
CN102125519B (zh) * 2011-02-28 2012-07-11 正大青春宝药业有限公司 稳定的盐酸替罗非班注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931441A (en) * 1988-11-09 1990-06-05 Luitpold Pharmaceuticals, Inc. Stabilized aqueous leucovorin calcium compositions
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
SI0859634T1 (en) 2002-04-30
DZ2110A1 (fr) 2002-07-22
BG102405A (en) 1999-08-31
JP3452367B2 (ja) 2003-09-29
TR199800716T2 (xx) 1998-07-21
CY2292B1 (en) 2003-07-04
EP0859634A1 (de) 1998-08-26
DE69619540T2 (de) 2002-08-22
PL185744B1 (pl) 2003-07-31
PT859634E (pt) 2002-07-31
CN1200676A (zh) 1998-12-02
IS1948B (is) 2004-10-13
MX9803275A (es) 1998-09-30
DK0859634T3 (da) 2002-03-25
HUP9902521A3 (en) 2000-01-28
CA2234364A1 (en) 1997-05-01
CZ290381B6 (cs) 2002-07-17
CO4770960A1 (es) 1999-04-30
KR100362799B1 (ko) 2003-07-16
CA2234364C (en) 2000-02-08
NO981869L (no) 1998-04-24
KR19990067020A (ko) 1999-08-16
BG63623B1 (bg) 2002-07-31
CN1158107C (zh) 2004-07-21
EA000628B1 (ru) 1999-12-29
HU228757B1 (en) 2013-05-28
NO324415B1 (no) 2007-10-08
DE69619540D1 (de) 2002-04-04
HUP9902521A2 (hu) 1999-12-28
MY116837A (en) 2004-04-30
WO1997015328A1 (en) 1997-05-01
IS4699A (is) 1998-03-24
SK282353B6 (sk) 2002-01-07
AU712755B2 (en) 1999-11-18
UA45423C2 (uk) 2002-04-15
PL326419A1 (en) 1998-09-14
EP0859634B1 (de) 2002-02-27
TW385248B (en) 2000-03-21
EA199800336A1 (ru) 1998-10-29
IL123790A0 (en) 1998-10-30
NZ323134A (en) 1999-11-29
NO981869D0 (no) 1998-04-24
EE9800134A (et) 1998-10-15
IL123790A (en) 2001-11-25
HK1017846A1 (en) 1999-12-03
BR9610878A (pt) 1999-07-13
JPH10512296A (ja) 1998-11-24
AU7718996A (en) 1997-05-15
ES2171749T3 (es) 2002-09-16
CZ127898A3 (cs) 1998-10-14
SA96170527B1 (ar) 2005-12-21
SK51298A3 (en) 1998-12-02
EE03518B1 (et) 2001-10-15

Similar Documents

Publication Publication Date Title
GEP20032957B (en) Nonpeptidyl Compositions
MY100343A (en) Amide derivative and external medicament comprising same
DE69328192D1 (de) Injizierbare Arzneizubereitungen enthaltend Taxanderivate
GB1418822A (en) Imidazo-and pyrimido-2,1-b-quinazolin-2-ones and a process for the preparation thereof
GB1147379A (en) 4-alkyl-dialkoxy-ª‡-methylphenethylamines and pharmacologically acceptable salts
ATE213648T1 (de) Arzneimittel enthaltend blutplättchenaggregationsinhibitoren
ES8402309A1 (es) Procedimiento para la preparacion de derivados de penem.
KR920004402A (ko) 신규 퀴놀린 카르복실산 유도체, 상기 화합물 함유 항균제 및 상기 화합물 제조 방법
KR900701262A (ko) 췌장염 등에 대한 치료제
GB1413454A (en) 4-alkoxyalkyleneoxy-5-benzylpyrimidines their preparation and pharmaceutical compositions thereof
NZ246598A (en) Trazodone derivatives; compounds and preparation, pharmaceutical compositions; intermediate compounds
KR980002033A (ko) 트리아졸 유도체 또는 그 염
GB1243953A (en) Benzdiazepine derivatives
GB1530848A (en) 2-(phenylalkylhydrazono)-propionic acid derivatives
GB1238095A (de)
GB1468079A (en) Ethanolamine derivatives
GB1298587A (en) Methods of contraception and contraceptive compositions
GB1504207A (en) Compositions containing p-alkanoyltoluene derivatives
ES8507524A1 (es) Un procedimiento para preparar derivados de tropona
GB1422895A (en) Anti-arthritic compositions comprising a phosphine or phosphite gold thiocyanate
GB1338172A (en) Local anesthetic compositions
GB1268747A (en) Novel 2-naphthyl-2-hydroxy-acetamidine derivatives, their preparation and use
GB1321541A (en) Sulphaguanidine derivatives
GB1272527A (en) Propanolamine derivatives
GB1333565A (en) Therapeutic compositions

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner